Literature DB >> 19735535

Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study.

M Schürks1, J E Buring, T Kurth.   

Abstract

Migraine is a common headache disorder that is increasingly being evaluated in population-based studies. The American Migraine Study II and the Women's Health Study (WHS) have successfully used 'modified' International Classification of Headache Disorders, 1st edition (ICHD-I) criteria to classify patients. Investigating agreement of self-reported migraine in large epidemiological studies with the criteria of the revised version [International Classification of Headache Disorders, 2nd edition (ICHD-II)] is sparse. We have investigated 1675 women with self-reported migraine participating in the WHS, who provided additional information on a detailed migraine questionnaire that allowed us to apply all ICHD-II criteria. In this sub-cohort, we confirmed self-reported migraine in > 87% of women when applying the ICHD-II criteria for migraine (71.5%) and probable migraine without aura (16.2%). In conclusion, there is excellent agreement between self-reported migraine and ICHD-II-based migraine classification in the WHS. In addition, questionnaire-based migraine assessment according to full ICHD-II criteria in large population-based studies is feasible.

Entities:  

Mesh:

Year:  2009        PMID: 19735535      PMCID: PMC2742765          DOI: 10.1111/j.1468-2982.2008.01835.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Low-dose aspirin for migraine prophylaxis in women.

Authors:  I M Benseñor; N R Cook; I M Lee; M J Chown; C H Hennekens; J E Buring
Journal:  Cephalalgia       Date:  2001-04       Impact factor: 6.292

3.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

4.  Migraine diagnosis and treatment: results from the American Migraine Study II.

Authors:  R B Lipton; S Diamond; M Reed; M L Diamond; W F Stewart
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Baseline characteristics of participants in the Women's Health Study.

Authors:  K M Rexrode; I M Lee; N R Cook; C H Hennekens; J E Buring
Journal:  J Womens Health Gend Based Med       Date:  2000 Jan-Feb

7.  Migraine and risk of cardiovascular disease in women.

Authors:  Tobias Kurth; J Michael Gaziano; Nancy R Cook; Giancarlo Logroscino; Hans-Christoph Diener; Julie E Buring
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

8.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  The International Classification of Headache Disorders.

Authors:  Jes Olesen
Journal:  Headache       Date:  2008-05       Impact factor: 5.887

  9 in total
  45 in total

1.  Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.

Authors:  Julianne R Lauring; Erik B Lehman; Timothy A Deimling; Richard S Legro; Cynthia H Chuang
Journal:  Am J Obstet Gynecol       Date:  2016-04-05       Impact factor: 8.661

2.  Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study.

Authors:  Tobias Kurth; Hans-Christoph Diener; Julie E Buring
Journal:  Cephalalgia       Date:  2011-06-14       Impact factor: 6.292

3.  Migraine and subsequent risk of breast cancer: a prospective cohort study.

Authors:  Anke C Winter; Kathryn M Rexrode; I-Min Lee; Julie E Buring; Rulla M Tamimi; Tobias Kurth
Journal:  Cancer Causes Control       Date:  2012-11-10       Impact factor: 2.506

4.  Migraine and risk of incident diabetes in women: a prospective study.

Authors:  Rebecca C Burch; Pamela M Rist; Anke C Winter; Julie E Buring; Aruna D Pradhan; Elizabeth W Loder; Tobias Kurth
Journal:  Cephalalgia       Date:  2012-07-17       Impact factor: 6.292

5.  Migraine, weight gain and the risk of becoming overweight and obese: a prospective cohort study.

Authors:  Anke C Winter; Lu Wang; Julie E Buring; Howard D Sesso; Tobias Kurth
Journal:  Cephalalgia       Date:  2012-08-08       Impact factor: 6.292

6.  Vascular risk factors, cardiovascular disease, and restless legs syndrome in women.

Authors:  Anke C Winter; Markus Schürks; Robert J Glynn; Julie E Buring; J Michael Gaziano; Klaus Berger; Tobias Kurth
Journal:  Am J Med       Date:  2013-03       Impact factor: 4.965

7.  Migraine, headache, and the risk of depression: Prospective cohort study.

Authors:  Pamela M Rist; Markus Schürks; Julie E Buring; Tobias Kurth
Journal:  Cephalalgia       Date:  2013-04-15       Impact factor: 6.292

Review 8.  Migraine and cardiovascular disease: systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Marcelo E Bigal; Julie E Buring; Richard B Lipton; Tobias Kurth
Journal:  BMJ       Date:  2009-10-27

9.  Sleep duration, vital exhaustion and perceived stress among pregnant migraineurs and non-migraineurs.

Authors:  Michelle A Williams; Sheena K Aurora; Ihunnaya O Frederick; Chunfang Qiu; Bizu Gelaye; Swee May Cripe
Journal:  BMC Pregnancy Childbirth       Date:  2010-11-03       Impact factor: 3.007

10.  Migraine and restless legs syndrome in men.

Authors:  Anke C Winter; Markus Schürks; Klaus Berger; Julie E Buring; J Michael Gaziano; Tobias Kurth
Journal:  Cephalalgia       Date:  2012-11-15       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.